CLINICAL_TRIALS trial_result · 2026-02-09

Clinical Trial Update: A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD [Phase 2]

Phase IIb study of glycopyrrolate inhalation solution in chronic obstructive pulmonary disease has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-02-09